Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Europe Flu Vaccine Market Report 2019

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

In this report, in the last several years, the EMEA (Europe, Middle East and Africa) market of Flu Vaccine developed rapidly, with an average growth rate of 7.50%. In 2016, EMEA (Europe, Middle East and Africa) Revenue of Flu Vaccine is nearly 750 M USD; the actual sales are about 77 M Doses.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 was about 43%, and the proportion was in decreasing trend from 2012 to 2016.

Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3years. The most proportion of Flu Vaccine is For Adults and Children over 3years, and the proportion in 2016 was about 75%.

The Europe in the EMEA was the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany was the largest consumption place with the consumption market share of 12%. Following Russia, France was the second largest consumption region, with the proportion of 11%.

Market competition is not intense. CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer and Johnson & Johnson, etc. are the leaders of the industry in the EMEA, with high-end customers in the Flu Vaccine market.


Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Flu Vaccine for these regions, from 2014 to 2026 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain

Europe Flu Vaccine market competition by top manufacturers/players, with Flu Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Flu Vaccine for each application, including
For Children (6 months to 3 years)
For Adults and Children over 3 years

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents


1 Report Overview

    1.1 Definition and Specification

    1.2 Report Overview

        1.2.1 Manufacturers Overview

        1.2.2 Regions Overview

        1.2.3 Type Overview

        1.2.4 Application Overview

    1.3 Industrial Chain

        1.3.1 Flu Vaccine Overall Industrial Chain

        1.3.2 Upstream

        1.3.3 Downstream

    1.4 Industry Situation

        1.4.1 Industrial Policy

        1.4.2 Product Preference

        1.4.3 Economic/Political Environment

    1.5 SWOT Analysis

2 Market Analysis by Types

    2.1 Overall Market Performance(Volume)

             2.1.1 Whole Virus Vaccines Market Performance (Volume)

             2.1.2 Split Virus Vaccines Market Performance (Volume)

             2.1.3 Subunit Vaccines Market Performance (Volume)

             2.1.4 Live Attenuated Virus Vaccines Market Performance (Volume)

    2.2 Overall Market Performance(Value)

             2.2.1 Whole Virus Vaccines Market Performance (Value)

             2.2.2 Split Virus Vaccines Market Performance (Value)

             2.2.3 Subunit Vaccines Market Performance (Value)

             2.2.4 Live Attenuated Virus Vaccines Market Performance (Value)

3 Product Application Market

    3.1 Overall Market Performance (Volume)

             3.1.1 For Children (6 months to 3 years) Market Performance (Volume)

             3.1.2 For Adults and Children over 3 years Market Performance (Volume)

4 Manufacturers Profiles/Analysis

    4.1 CSL

        4.1.1 CSL Profiles

        4.1.2 CSL Product Information

        4.1.3 CSL Flu Vaccine Business Performance

        4.1.4 CSL Flu Vaccine Business Development and Market Status

    4.2 GSK

        4.2.1 GSK Profiles

        4.2.2 GSK Product Information

        4.2.3 GSK Flu Vaccine Business Performance

        4.2.4 GSK Flu Vaccine Business Development and Market Status

    4.3 Sanofi Pasteur

        4.3.1 Sanofi Pasteur Profiles

        4.3.2 Sanofi Pasteur Product Information

        4.3.3 Sanofi Pasteur Flu Vaccine Business Performance

        4.3.4 Sanofi Pasteur Flu Vaccine Business Development and Market Status

    4.4 Mylan

        4.4.1 Mylan Profiles

        4.4.2 Mylan Product Information

        4.4.3 Mylan Flu Vaccine Business Performance

        4.4.4 Mylan Flu Vaccine Business Development and Market Status

    4.5 AstraZeneca

        4.5.1 AstraZeneca Profiles

        4.5.2 AstraZeneca Product Information

        4.5.3 AstraZeneca Flu Vaccine Business Performance

        4.5.4 AstraZeneca Flu Vaccine Business Development and Market Status

    4.6 Pfizer

        4.6.1 Pfizer Profiles

        4.6.2 Pfizer Product Information

        4.6.3 Pfizer Flu Vaccine Business Performance

        4.6.4 Pfizer Flu Vaccine Business Development and Market Status

    4.7 Johnson & Johnson

        4.7.1 Johnson & Johnson Profiles

        4.7.2 Johnson & Johnson Product Information

        4.7.3 Johnson & Johnson Flu Vaccine Business Performance

        4.7.4 Johnson & Johnson Flu Vaccine Business Development and Market Status

5 Market Performance for Manufacturers

    5.1 Europe Flu Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020

    5.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020

    5.3 Europe Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

    5.4 Europe Flu Vaccine Gross Margin of Manufacturers 2014-2020

    5.5 Market Concentration

6 Regions Market Performance for Manufacturers

    6.1 Germany Market Performance for Manufacturers

        6.1.1 Germany Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.1.2 Germany Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.1.3 Germany Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.1.4 Germany Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.1.5 Market Concentration

    6.2 UK Market Performance for Manufacturers

        6.2.1 UK Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.2.2 UK Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.2.3 UK Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.2.4 UK Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.2.5 Market Concentration

    6.3 France Market Performance for Manufacturers

        6.3.1 France Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.3.2 France Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.3.3 France Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.3.4 France Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.3.5 Market Concentration

    6.4 Russia Market Performance for Manufacturers

        6.4.1 Russia Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.4.2 Russia Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.4.3 Russia Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.4.4 Russia Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.4.5 Market Concentration

    6.5 Benelux Market Performance for Manufacturers

        6.5.1 Benelux Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.5.2 Benelux Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.5.3 Benelux Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.5.4 Benelux Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.5.5 Market Concentration

    6.6 Italy Market Performance for Manufacturers

        6.6.1 Italy Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.6.2 Italy Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.6.3 Italy Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.6.4 Italy Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.6.5 Market Concentration

    6.7 Spain Market Performance for Manufacturers

        6.7.1 Spain Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.7.2 Spain Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.7.3 Spain Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.7.4 Spain Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.7.5 Market Concentration

    6.8  Market Performance for Manufacturers

        6.8.1  Flu Vaccine Sales (K Units) and Share of Manufacturers 2014-2020

        6.8.2  Flu Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020

        6.8.3  Flu Vaccine Price (USD/Unit) of Manufacturers 2014-2020

        6.8.4  Flu Vaccine Gross Margin of Manufacturers 2014-2020

        6.8.5 Market Concentration

7 Europe  Flu Vaccine Market Performance (Sales Point)

    7.1 Europe Flu Vaccine Sales (K Units) and Market Share by Regions 2014-2020

    7.2 Europe Flu Vaccine Revenue (M USD) and Market Share by Regions 2014-2020

    7.3 Europe Flu Vaccine Price (USD/Unit) by Regions 2014-2020

    7.4 Europe Flu Vaccine Gross Margin by Regions 2014-2020

8 Development Trend for Regions (Sales Point)

    8.1 Europe Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.2 Germany Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.3 UK Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.4 France Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.5 Russia Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.6 Benelux Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.7 Italy Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

    8.8 Spain Flu Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020

9 Upstream Source, Technology and Cost

    9.1 Upstream Source

    9.2 Technology

    9.3 Cost

10 Channel Analysis

    10.1 Market Channel

    10.2 Distributors

11 Consumer Analysis

    11.1 For Children (6 months to 3 years) Industry

    11.2 For Adults and Children over 3 years Industry

12 Market Forecast 2021-2026

    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026

        12.1.1 Europe Flu Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026

        12.1.2 Europe Flu Vaccine Sales (K Units) and Growth Rate 2021-2026

        12.1.3 Germany Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.1.4 UK Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.1.5 France Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.1.6 Russia Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.1.7 Benelux Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.1.8 Italy Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.1.9 Spain Flu Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

    12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026

        12.2.1 Overall Market Performance

        12.2.2 Whole Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.2.3 Split Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.2.4 Subunit Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

        12.2.5 Live Attenuated Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026

    12.3 Sales Forecast by Application 2021-2026

        12.3.1 Overall Market Performance

        12.3.2 For Children (6 months to 3 years) Sales and and Growth Rate 2021-2026

        12.3.3 For Adults and Children over 3 years Sales and and Growth Rate 2021-2026

    12.4 Price (USD/Unit) and Gross Profit Forecast

        12.4.1 Europe Flu Vaccine Price (USD/Unit) Trend 2021-2026

        12.4.2 Europe Flu Vaccine Gross Profit Trend 2021-2026

13 Conclusion

Chemicals and Materials

Europe Vanadium Market Size, Share, Trends & Analysis by Grade Type (FeV40, FeV50, FeV60, FeV80), by Production Process (Aluminothermic Reduction Technique, Silicon Reduction Technique), by Application (Iron and Steel, Chemical, Titanium Alloys, Others), by End User (Automotive Chemical, Energy Storage, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,380   Date : Oct 2024
  Category : Chemicals and Materials   Pages : 199
Healthcare and Pharmaceuticals

Europe Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,595   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 183
Healthcare and Pharmaceuticals

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 196
Consumer Goods and Retail

Europe Anti-Pollution Mask Market Size, Share, Trends & Analysis by Type (Disposable, Reusable), by Filter Type (Combination Filter, Gas and Odour Filter, Particulate Filter), by Distribution Channel (Online, Offline) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,590   Date : Oct 2024
  Category : Consumer Goods and Retail   Pages : 179
Consumer Goods and Retail

Europe Ethnic Wear Market Size, Share, Trends & Analysis by End User (Men, Women, Children), by Type (Fusion Wear, Traditional Wear), by Distribution Channel (Online, Offline) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,650   Date : Oct 2024
  Category : Consumer Goods and Retail   Pages : 176

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Europe Vanadium Market Size, Share, Trends & Analysis By Grade Type (FeV40, FeV50, FeV60, FeV...
View More
Europe Vascular Closure Devices Market Size, Share, Trends & Analysis By Type (Active Approxi...
View More
Europe Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT,...
View More
Europe Anti-Pollution Mask Market Size, Share, Trends & Analysis By Type (Disposable, Reusabl...
View More
Europe Ethnic Wear Market Size, Share, Trends & Analysis By End User (Men, Women, Children), ...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved